(Q43427810)

23 November 2017

Direct comparison of four adeno-associated virus serotypes in mediating the production of antiangiogenic proteins in mouse muscle (English)

1 reference

23 November 2017

angiogenesis inhibitor

1 reference

Mayu Isotani

1

1 reference

23 November 2017

Koichi Miyake

2

1 reference

23 November 2017

Noriko Miyake

3

1 reference

23 November 2017

Yukihiko Hirai

4

1 reference

23 November 2017

Takashi Shimada

5

1 reference

23 November 2017

1 June 2011

1 reference

23 November 2017

1 reference

23 November 2017

29

1 reference

23 November 2017

5

1 reference

23 November 2017

353-359

1 reference

Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene

23 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Liposome transfected to plasmid-encoding endostatin gene combined with radiotherapy inhibits liver cancer growth in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Adeno-associated virus-mediated delivery of a mutant endostatin in combination with carboplatin treatment inhibits orthotopic growth of ovarian cancer and improves long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Combined immunotherapy and antiangiogenic therapy of cancer with microencapsulated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Posttranslational modifications of recombinant myotube-synthesized human factor IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Superior neovascularization and muscle regeneration in ischemic skeletal muscles following VEGF gene transfer by rAAV1 pseudotyped vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Therapeutic levels of factor IX expression using a muscle-specific promoter and adeno-associated virus serotype 1 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Adeno-associated viral vector-mediated expression of endostatin inhibits tumor growth and metastasis in an orthotropic pancreatic cancer model in hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Antiangiogenic gene therapy of myeloproliferative disease developed in transgenic mice expressing P230 bcr/abl

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Gene therapy for pyruvate dehydrogenase E1alpha deficiency using recombinant adeno-associated virus 2 (rAAV2) vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

New strategy for in vivo transgene expression in corneal epithelial progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

AAV1 mediated co-expression of formylglycine-generating enzyme and arylsulfatase a efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Delivery of alpha- and beta-sarcoglycan by recombinant adeno-associated virus: efficient rescue of muscle, but differential toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Gene transfer into skeletal muscle using novel AAV serotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Systemic protein delivery by muscle-gene transfer is limited by a local immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.584585

10.3109/07357907.2011.584585

21 January 2018

Identifiers

DOI

1 reference

release_i4f6yffpujecxj4d5l2e5steku

23 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/i4f6yffpujecxj4d5l2e5steku

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference